Skip to main content
TipRanks
Go Ultimate75% OFF

Kestra Medical Technologies Ltd. (KMTS) Stock Statistics & Valuation Metrics

19 Followers

Total Valuation

Kestra Medical Technologies Ltd. has a market cap or net worth of $1.71B. The enterprise value is $1.21B.

Market Cap
$1.71B
Enterprise Value
$1.21B

Share Statistics

Kestra Medical Technologies Ltd. has 59,561,794 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
59,561,794
Owned by Insiders
43.97%
Owned by Institutions
43.75%

Financial Efficiency

Kestra Medical Technologies Ltd.’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -43.73%.

Return on Equity (ROE)
-0.51
Return on Assets (ROA)
-0.37
Return on Invested Capital (ROIC)
-43.73%
Return on Capital Employed (ROCE)
-0.44
Revenue Per Employee
214.73K
Profits Per Employee
-297.09K
Employee Count
443
Asset Turnover
0.27
Inventory Turnover
6.90

Valuation Ratios

The current PE Ratio of Kestra Medical Technologies Ltd. is -10.73. Kestra Medical Technologies Ltd.’s PEG ratio is -0.68.

PE Ratio
-10.73
PS Ratio
15.98
PB Ratio
7.54
Price to FCF
-13.89
Price to Operating Cash Flow
-19.12
PEG Ratio
-0.68

Income Statement

In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 95.13M and earned -131.61M in profits. Earnings per share was -2.43.

Revenue
95.13M
Gross Profit
48.86M
Operating Income
-134.74M
Pretax Income
-131.32M
Net Income
-131.61M
EBITDA
-136.93M
Earnings Per Share (EPS)
-2.43

Cash Flow

In the last 12 months, operating cash flow was -87.72M and capital expenditures -35.06M, giving a free cash flow of -122.78M billion.

Operating Cash Flow
-87.72M
Free Cash Flow
-122.78M
Free Cash Flow per Share
-2.10

Dividends & Yields

Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-7.20%
Earnings Yield
-8.94%

Stock Price Statistics

Beta
1.21
52-Week Price Change
14.97%
50-Day Moving Average
27.38
200-Day Moving Average
24.07
Relative Strength Index (RSI)
49.45
Average Volume (3m)
411.62K

Important Dates

Kestra Medical Technologies Ltd. upcoming earnings date is Dec 10, 2026, TBA (Not Confirmed).

Last Earnings Date
Sep 14, 2026
Next Earnings Date
Dec 10, 2026
Ex-Dividend Date
―

Financial Position

Kestra Medical Technologies Ltd. as a current ratio of 4.41, with Debt / Equity ratio of 18.02%

Current Ratio
4.41
Quick Ratio
4.28
Debt to Market Cap
0.04
Net Debt to EBITDA
0.39
Interest Coverage Ratio
-17.85

Taxes

In the past 12 months, Kestra Medical Technologies Ltd. has paid 294.00K in taxes.

Income Tax
294.00K
Effective Tax Rate
-0.00

Enterprise Valuation

Kestra Medical Technologies Ltd. EV to EBITDA ratio is -13.11, with an EV/FCF ratio of -13.96.

EV to Sales
16.06
EV to EBITDA
-13.11
EV to Free Cash Flow
-13.96
EV to Operating Cash Flow
-19.54

Balance Sheet

Kestra Medical Technologies Ltd. has $198.91M in cash and marketable securities with $76.45M in debt, giving a net cash position of $122.47M billion.

Cash & Marketable Securities
$198.91M
Total Debt
$76.45M
Net Cash
$122.47M
Net Cash Per Share
$2.06
Tangible Book Value Per Share
$3.80

Margins

Gross margin is 53.89%, with operating margin of -134.48%, and net profit margin of -140.43%.

Gross Margin
53.89%
Operating Margin
-134.48%
Pretax Margin
-140.14%
Net Profit Margin
-140.43%
EBITDA Margin
-122.51%
EBIT Margin
-131.27%

Analyst Forecast

The average price target for Kestra Medical Technologies Ltd. is $30.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$30.60
Price Target Upside
6.84% Upside
Analyst Consensus
Strong Buy
Analyst Count
5
Revenue Growth Forecast
60.72%
EPS Growth Forecast
-5.66%

Scores

Smart Score
2
AI Score
55